VINTOR

This brand name is authorized in Albania, Nigeria, Turkey.

Active ingredients

The drug VINTOR contains one active pharmaceutical ingredient (API):

1	Fingolimod UNII G926EC510T - FINGOLIMOD HYDROCHLORIDE
	Fingolimod is a sphingosine 1-phosphate receptor modulator. Fingolimod is metabolised by sphingosine kinase to the active metabolite fingolimod phosphate. By acting as a functional antagonist of S1P receptors on lymphocytes, fingolimod phosphate blocks the capacity of lymphocytes to egress from lymph nodes, causing a redistribution, rather than depletion, of lymphocytes.
	Read more about Fingolimod

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AE01	Fingolimod	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AE Sphingosine-1-phosphate (S1P) receptor modulators
Discover more medicines within L04AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	584/410
NG	Registered Drug Product Database	A6-0076, A6-0077
Switch country to Nigeria in order to find specific presentations of VINTOR
TR	İlaç ve Tıbbi Cihaz Kurumu	8699536150413, 8699536150420